Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Uras

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
European Journal of Breast Health|July 18, 2019
Cost effectiveness of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in a Middle-Income Country, Turkey: Results of a Prospective Multicenter StudyVahit Özmen, Burcu Çakar, Erhan Gökmen, et al.
Cureus|April 16, 2016
Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in TurkeyVahit Ozmen, Ajlan Atasoy, Erhan Gokmen, et al.
Diseases (Basel, Switzerland)|June 25, 2025
Association of Mitochondrial DNA Copy Number Variations with Triple-Negative Breast Cancer: A Potential Biomarker StudyKarin Manto, Sevdican Ustun Yilmaz, Zeliha Pala Kara, et al.
Annals of Surgical Oncology|December 9, 2024
ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is AdministeredNeslihan Cabioglu, Hasan Karanlik, Abdullah Igci, et al.
European Journal of Breast Health|October 5, 2023
Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk CategorizationÇağlar Ünal, Tolga Özmen, Çetin Ordu, et al.
Frontiers in Medicine|October 20, 2023
Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacyNeslihan Cabioglu, Cihan Uras, Halime Mutlu, et al.
World Journal of Surgery|August 2, 2025
Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence Score Testing: Long-Term Survival Update of a Prospective Multicenter Study in Türkiye According to Different Cut-OffsEnver Özkurt, Çetin Ordu, Ertan Koç, et al.
The Journal of Breast Health|March 24, 2017
Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in TurkeyVahit Özmen, Ajlan Atasoy, Erhan Gökmen, et al.
European Journal of Breast Health|December 25, 2025
Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 2: Systemic TreatmentElif Şenocak Taşçı, Özlem Sönmez, Başak Oyan Uluç, et al.
Breast (Edinburgh, Scotland)|February 19, 2010
Radioguided occult lesion localization (ROLL) for non-palpable breast cancer: a comparison between day-before and same-day protocolsFatih Aydogan, Volkan Ozben, Varol Celik, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
European Journal of Breast Health|July 18, 2019
Cost effectiveness of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in a Middle-Income Country, Turkey: Results of a Prospective Multicenter StudyVahit Özmen, Burcu Çakar, Erhan Gökmen, et al.
Cureus|April 16, 2016
Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in TurkeyVahit Ozmen, Ajlan Atasoy, Erhan Gokmen, et al.
Diseases (Basel, Switzerland)|June 25, 2025
Association of Mitochondrial DNA Copy Number Variations with Triple-Negative Breast Cancer: A Potential Biomarker StudyKarin Manto, Sevdican Ustun Yilmaz, Zeliha Pala Kara, et al.
Annals of Surgical Oncology|December 9, 2024
ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is AdministeredNeslihan Cabioglu, Hasan Karanlik, Abdullah Igci, et al.
European Journal of Breast Health|October 5, 2023
Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk CategorizationÇağlar Ünal, Tolga Özmen, Çetin Ordu, et al.
Frontiers in Medicine|October 20, 2023
Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacyNeslihan Cabioglu, Cihan Uras, Halime Mutlu, et al.
World Journal of Surgery|August 2, 2025
Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence Score Testing: Long-Term Survival Update of a Prospective Multicenter Study in Türkiye According to Different Cut-OffsEnver Özkurt, Çetin Ordu, Ertan Koç, et al.
The Journal of Breast Health|March 24, 2017
Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in TurkeyVahit Özmen, Ajlan Atasoy, Erhan Gökmen, et al.
European Journal of Breast Health|December 25, 2025
Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 2: Systemic TreatmentElif Şenocak Taşçı, Özlem Sönmez, Başak Oyan Uluç, et al.
Breast (Edinburgh, Scotland)|February 19, 2010
Radioguided occult lesion localization (ROLL) for non-palpable breast cancer: a comparison between day-before and same-day protocolsFatih Aydogan, Volkan Ozben, Varol Celik, et al.
Pageof 9